NCT07323693

Brief Summary

To evaluate and compare the clinical effectiveness of a Bioactive Desensitizer Gel (which releases calcium and phosphate to form hydroxyapatite) versus a standard 5% Sodium Fluoride (NaF) Varnish in reducing cervical dentin hypersensitivity (CDH) in adult patients over a period of 6 months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 20, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 20, 2025

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

December 23, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 7, 2026

Completed
Last Updated

January 7, 2026

Status Verified

December 1, 2025

Enrollment Period

10 months

First QC Date

December 23, 2025

Last Update Submit

December 23, 2025

Conditions

Keywords

Dentin hypersentivity

Outcome Measures

Primary Outcomes (1)

  • Visual analog scale (VAS)

    A VAS is a line that is 10 cm in length, the extremes of which represent the limits of pain, a patient may experience an external stimulus (The left endpoint designated no pain was marked as 0 and the right endpoint designated sever pain was marked as 10). Patients will be asked to place a mark on the 10 cm line that indicated their dentin hypersensitivity intensity

    Change from the Baseline, 1 week, 1 months, 3 months, 6 months

Secondary Outcomes (1)

  • Level of Pain Assessment using The Schiff sensitivity scale

    Change from the Baseline, 1 week, 1 months, 3 months, 6 months

Study Arms (2)

Bioactive Desenstizer

EXPERIMENTAL

A micro-brush applicator was saturated with the material (Predicta Bioactive Desensitizer Gel) and massaged it into the tooth for 30-40 secs.Using a rubbing motion was used to liquefy the gel and allow it to penetrate the surface

Procedure: Treatment

sodium fluoride varnish

ACTIVE COMPARATOR
Procedure: Treatment

Interventions

TreatmentPROCEDURE

A micro-brush applicator was saturated with the material (Predicta Bioactive Desensitizer Gel) and massaged it into the tooth for 30-40 secs. Using a rubbing motion was used to liquefy the gel and allow it to penetrate the surface

Bioactive Desenstizer

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • With ≥1 sensitive tooth and with exposed dentin in the upper or lower dental arches.
  • Grade IV gingival recession.
  • Schiff sensitivity score needed to be ≥2, indicating that application of a jet of air makes the patient respond and move or requests discontinuation of the stimuli application.

You may not qualify if:

  • Domestic or in-office fluoride application and bleaching 6 months before beginning of treatment
  • Long-term use of anti-inflammatory, analgesic and psychotropic drugs.
  • Allergies to product ingredients
  • Eating disorders, systemic conditions that cause or predispose patients to develop dentin hypersensitivity (for example, gastroesophageal reflux disease, GERD)
  • Excessive dietary or environmental exposure to acids.
  • Orthodontic appliance treatment within the previous three months.
  • Periodontal surgery within the previous three months before the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry

Cairo, Egypt

Location

MeSH Terms

Conditions

Dentin Sensitivity

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Conservative dentistry department, Faculty of Dentistry, Cairo University

Study Record Dates

First Submitted

December 23, 2025

First Posted

January 7, 2026

Study Start

November 20, 2024

Primary Completion

September 20, 2025

Study Completion

December 20, 2025

Last Updated

January 7, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations